Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable Hepatocellular Carcinoma

NCT05546879 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT05546879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05546879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable Hepatocellular Carcinoma
Lead sponsor
University Hospital, Grenoble
Phase
Phase 1
Overall status
Active, not recruiting
Start date
March 15, 2023
Completion date
March 19, 2029
Enrollment
43 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma